Table 1.
Baseline characteristics for all claims reimbursed between January 2006 and December 2013
| NSAID/Coxibs | Paracetamol | Metamizole | Weak Opioids | Strong Opioids | |
|---|---|---|---|---|---|
| Number of claims: n total | 2'156'620 | 4'746'942 | 931'129 | 1'322'272 | 807'835 |
| Number of persons: n | 693'928 | 1'098'925 | 292'403 | 268'143 | 121'455 |
| Morphine equivalent: median (IQR)a | - | - | - | 180 (531) | 300 (2680.1) |
| Male: n (%) | 293'011 (42.2) | 484'176 (44.1) | 120'609 (41.2) | 111'888 (41.7) | 50'329 (41.4) |
| Female: n (%) | 400'917 (57.8) | 614'749 (55.9) | 171'794 (58.8) | 156'255 (58.3) | 71'126 (58.6) |
| Age: median (IQR) | 39 (41) | 38 (45) | 54 (35) | 57 (31) | 64 (30) |
| Age male: median (IQR) | 36 (43) | 36 (47) | 52 (33) | 55 (29) | 61 (29) |
| Age female: median (IQR) | 41 (40) | 40 (43) | 55 (37) | 59 (32) | 67 (31) |
| German partb: n persons (%) | 464'237 (66.9%) | 766'415 (69.7%) | 257'420 (88.0%) | 195'149 (72.8%) | 101'664 (83.7%) |
| French partb: n persons (%) | 195'934 (28.2%) | 259'895 (23.6%) | 22'835 (7.8%) | 57'929 (21.6%) | 15'642 (12.9%) |
| Italian partb: n persons (%) | 33'757 (4.9%) | 72'615 (6.6%) | 12'148 (4.2%) | 15'065 (5.6%) | 4'149 (3.4%) |
| German partb: n claims (%) | 1'416'848 (65.7%) | 3'059'364 (64.4%) | 845'951 (90.9%) | 962'477 (72.8%) | 671'079 (83.1%) |
| French partb: n claims (%) | 637'028 (29.5%) | 1'320'874 (27.8%) | 54'124 (5.8%) | 286'570 (21.7%) | 109'364 (13.5%) |
| Italian partb: n claims (%) | 102'744 (4.8%) | 366'704 (7.7%) | 31'054 (3.3%) | 73'225 (5.5%) | 27'392 (3.4%) |
amorphine equivalents in milligram
bnumbers calculated based on the area of residency (canton)